Evidence map›Paper›PMID 33572770›Full record

ArticleInternational journal of environmental research and public health2021

Associations of Perfluoroalkyl Substances with Prevalence of Metabolic Syndrome in Highly Exposed Young Adult Community Residents-A Cross-Sectional Study in Veneto Region, Italy.

Maryam Zare Jeddi, Teresa Dalla Zuanna, Giulia Barbieri, Aline S C Fabricio, Francesca Daprà, Tony Fletcher, Francesca Russo, Gisella Pitter, Cristina Canova

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Maryam Zare JeddiUnit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, 35131 Padova, Italy.ORCID 0000-0002-9505-812X
Teresa Dalla ZuannaUnit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, 35131 Padova, Italy.ORCID 0000-0003-1244-404X
Giulia BarbieriUnit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, 35131 Padova, Italy.ORCID 0000-0002-3531-0725
Aline S C FabricioVeneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.ORCID 0000-0003-0153-8809
Francesca DapràLaboratory Department-Regional Agency for Environmental Prevention and Protection-Veneto Region, 37135 Verona, Italy.
Tony FletcherLondon School of Hygiene and Tropical Medicine, London WC1H 9SH, UK.
Francesca RussoDirectorate of Prevention, Food Safety, and Veterinary Public Health-Veneto Region, 30123 Venice, Italy.
Gisella PitterScreening and Health Impact Assessment Unit, Azienda Zero-Veneto Region, 35131 Padova, Italy.
Cristina CanovaUnit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, 35131 Padova, Italy.
University of Padua · ITRegione del Veneto · ITAgenzia Regionale per la Protezione Ambientale del Piemonte · ITIstituto Oncologico Veneto · ITLondon School of Hygiene & Tropical Medicine · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies on the association between perfluoroalkyl substances (PFAS) and metabolic syndrome (MetS) are limited, and results are inconsistent. We aimed to examine the associations between PFAS serum levels and the prevalence of MetS among highly exposed young adults (ages 20-39) residents of a large area of the Veneto Region (North-Eastern Italy) primarily stemming from PFAS water contamination before September 2013. A total of 15,876 eligible young adult residents living in the investigated municipalities were enrolled in the study from January 2017 to July 2019.

methodsMetS was defined by using a modified harmonized definition requiring the presence of 3 of the following: obesity (body mass index ≥30), elevated triglyceride (TG), reduced high-density lipoprotein cholesterol, elevated blood pressure, and hemoglobin A1c ≥ 6.1% or self-reported diabetes mellitus or drug treatment for hyperglycemia. Multivariable generalized additive models were performed to identify the associations between four serum PFAS, including perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perfluorohexane sulfonic acid (PFHxS), and perfluorononanoic acid (PFNA), and risk of MetS controlling for potential confounders.

resultsA total of 1282 participants (8.1%) met the criteria of MetS with a higher prevalence among men. PFOA, PFHxS, and PFNA were not associated with the risk of MetS, whereas PFOS showed a consistent protective effect against the risk of MetS (OR 0.76, (95% CI: 0.69, 0.85) per ln-PFOS). However, we found statistically significant positive associations between PFAS serum levels and individual components of MetS, mainly elevated blood pressure and elevated TG.

conclusionOur results did not support a consistent association between PFAS and MetS and conflicting findings were observed for individual components of MetS.

Indexed as

Alkanesulfonic AcidsEnvironmental PollutantsFluorocarbonsMetabolic SyndromeAdultCaprylatesCross-Sectional StudiesHumansItalyMalePrevalenceYoung AdultAlkanesulfonic AcidsCaprylatesEnvironmental PollutantsFluorocarbonsbiomonitoringcardiovascular risk factorsepidemiologymetabolically healthy obesitymetabolic syndromePFAS

Identifiers

PMID33572770
PMCPMC7908308
OpenAlexW3128703740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.